| 前收市價 | 27.69 |
| 開市 | 28.05 |
| 買盤 | 28.70 x 200 |
| 賣出價 | 28.79 x 100 |
| 今日波幅 | 27.97 - 29.00 |
| 52 週波幅 | 26.32 - 42.72 |
| 成交量 | |
| 平均成交量 | 564,598 |
| 市值 | 18.59B |
| Beta 值 (5 年，每月) | 0.78 |
| 市盈率 (最近 12 個月) | 30.26 |
| 每股盈利 (最近 12 個月) | 0.95 |
| 業績公佈日 | 2024年5月02日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 41.15 |
Investor's Business DailyGenmab Takes The Next Step In Its 'Evolution' With A $1.8 Billion Takeover
Genmab stock slumped Wednesday after the Danish biotech announced it will buy privately held ProfoundBio for $1.8 billion.
Insider Monkey30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
Insider MonkeyGenmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript
Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript February 14, 2024 Genmab A/S misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.35. Genmab A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you […]
